These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 35306431)

  • 1. Neutrophil extracellular traps (NETs) in patients with STEMI. Association with percutaneous coronary intervention and antithrombotic treatments.
    Ferré-Vallverdú M; Latorre AM; Fuset MP; Sánchez E; Madrid I; Ten F; Vallés J; Santos MT; Bonanad S; Moscardó A
    Thromb Res; 2022 May; 213():78-83. PubMed ID: 35306431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Culprit site extracellular DNA and microvascular obstruction in ST-elevation myocardial infarction.
    Mangold A; Ondracek AS; Hofbauer TM; Scherz T; Artner T; Panagiotides N; Beitzke D; Ruzicka G; Nistler S; Wohlschläger-Krenn E; Winker R; Quehenberger P; Traxler-Weidenauer D; Spannbauer A; Gyöngyösi M; Testori C; Lang IM
    Cardiovasc Res; 2022 Jun; 118(8):2006-2017. PubMed ID: 34173822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 16-year follow-up of the Danish Acute Myocardial Infarction 2 (DANAMI-2) trial: primary percutaneous coronary intervention vs. fibrinolysis in ST-segment elevation myocardial infarction.
    Thrane PG; Kristensen SD; Olesen KKW; Mortensen LS; Bøtker HE; Thuesen L; Hansen HS; Abildgaard U; Engstrøm T; Andersen HR; Maeng M
    Eur Heart J; 2020 Feb; 41(7):847-854. PubMed ID: 31504424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term efficacy of angiotensin receptor-neprilysin inhibitor treatment in patients with ST-segment elevation myocardial infarction with reduced ejection fraction after primary percutaneous coronary intervention: a propensity score matching study.
    Zhang Q; Qiao B; Han Y; Sun S; Wang B; Wei S
    BMC Cardiovasc Disord; 2022 Nov; 22(1):463. PubMed ID: 36333668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deoxyribonuclease 1 Q222R single nucleotide polymorphism and long-term mortality after acute myocardial infarction.
    Hofbauer TM; Mangold A; Ondracek AS; Panzenböck A; Scherz T; Müller J; Distelmaier K; Seidl V; Kastl S; Müller-Nurasyid M; Peters A; Strauch K; Winker R; Wohlschläger-Krenn E; Nistler S; Lang IM
    Basic Res Cardiol; 2021 Apr; 116(1):29. PubMed ID: 33891165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).
    Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B;
    Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between TRAIL and Left Ventricular Ejection Fraction in Patients with ST-Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention.
    Teringova E; Kozel M; Knot J; Kocka V; Benesova K; Tousek P
    Biomed Res Int; 2018; 2018():3709084. PubMed ID: 30112383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of pre-angioplasty antithrombotic therapy administration on coronary reperfusion in ST-segment elevation myocardial infarction: Does time matter?
    Giralt T; Ribas N; Freixa X; Sabaté M; Caldentey G; Tizón-Marcos H; Carrillo X; García-Picart J; Lidón RM; Cárdenas M; Pérez-Fernández S; Mauri J; Vaquerizo B
    Int J Cardiol; 2021 Feb; 325():9-15. PubMed ID: 32991944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ST-elevation myocardial infarction with reduced left ventricular ejection fraction: Insights into persisting left ventricular dysfunction. A pPCI-registry analysis.
    Stolfo D; Cinquetti M; Merlo M; Santangelo S; Barbati G; Alonge M; Vitrella G; Rakar S; Salvi A; Perkan A; Sinagra G
    Int J Cardiol; 2016 Jul; 215():340-5. PubMed ID: 27128558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of ST-Segment Resolution in Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention (from the 5-Year Outcomes of the EXAMINATION [Evaluation of the Xience-V Stent in Acute Myocardial Infarction] Trial).
    Spitaleri G; Brugaletta S; Scalone G; Moscarella E; Ortega-Paz L; Pernigotti A; Gomez-Lara J; Cequier A; Iñiguez A; Serra A; Jiménez-Quevedo P; Mainar V; Campo G; Tespili M; den Heijer P; Bethencourt A; Vazquez N; Valgimigli M; Serruys PW; Sabaté M
    Am J Cardiol; 2018 May; 121(9):1039-1045. PubMed ID: 29544865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes after delayed primary percutaneous coronary intervention vs. pharmaco-invasive strategy in ST-segment elevation myocardial infarction in Norway.
    Jortveit J; Pripp AH; Halvorsen S
    Eur Heart J Cardiovasc Pharmacother; 2022 Aug; 8(5):442-451. PubMed ID: 34038535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Ticagrelor Versus Clopidogrel Treatment in Patients With ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Tang X; Li R; Jing Q; Wang Q; Liu P; Zhang P; Liu Y
    J Cardiovasc Pharmacol; 2016 Aug; 68(2):115-20. PubMed ID: 27010809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of thrombus aspiration during primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction].
    Shen C; Wang LF
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Jan; 47(1):49-55. PubMed ID: 30669810
    [No Abstract]   [Full Text] [Related]  

  • 14. Time-of-day at symptom onset was not associated with infarct size and long-term prognosis in patients with ST-segment elevation myocardial infarction.
    Sager HB; Husser O; Steffens S; Laugwitz KL; Schunkert H; Kastrati A; Ndrepepa G; Kessler T
    J Transl Med; 2019 May; 17(1):180. PubMed ID: 31142323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five-year outcomes following timely primary percutaneous intervention, late primary percutaneous intervention, or a pharmaco-invasive strategy in ST-segment elevation myocardial infarction: the FAST-MI programme.
    Danchin N; Popovic B; Puymirat E; Goldstein P; Belle L; Cayla G; Roubille F; Lemesle G; Ferrières J; Schiele F; Simon T;
    Eur Heart J; 2020 Feb; 41(7):858-866. PubMed ID: 31539043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parenteral antithrombotic therapy during primary percutaneous coronary intervention.
    Fortuni F; Ferlini M; Leonardi S
    Minerva Cardioangiol; 2018 Aug; 66(4):411-421. PubMed ID: 29393605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect on myocardial perfusion and clinical outcome of intracoronary nicorandil injection prior to percutaneous coronary intervention in ST-segment elevation myocardial infarction].
    Wang ZQ; Chen MX; Liu DL; Zheng WX; Cao XZ; Chen H; Huang MF; Luo ZR
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):26-33. PubMed ID: 28100342
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy and safety of bivalirudin application during primary percutaneous coronary intervention in older patients with acute ST-segment elevation myocardial infarction.
    Chen H; Yu X; Kong X; Li L; Wu J; Ma L
    J Int Med Res; 2020 Sep; 48(9):300060520947942. PubMed ID: 32985292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship Between Arterial Access and Outcomes in ST-Elevation Myocardial Infarction With a Pharmacoinvasive Versus Primary Percutaneous Coronary Intervention Strategy: Insights From the STrategic Reperfusion Early After Myocardial Infarction (STREAM) Study.
    Shavadia J; Welsh R; Gershlick A; Zheng Y; Huber K; Halvorsen S; Steg PG; Van de Werf F; Armstrong PW
    J Am Heart Assoc; 2016 Jun; 5(6):. PubMed ID: 28525886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction Via Radial Access Anticoagulated With Bivalirudin Versus Heparin: A Report From the National Cardiovascular Data Registry.
    Jovin IS; Shah RM; Patel DB; Rao SV; Baklanov DV; Moussa I; Kennedy KF; Secemsky EA; Yeh RW; Kontos MC; Vetrovec GW
    JACC Cardiovasc Interv; 2017 Jun; 10(11):1102-1111. PubMed ID: 28527778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.